AI Applications for Drug Discovery and Development is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Heather Arnett
Vice President Research at NuMedii, USA

Profile

Heather is leading research discovery and development at NuMedii, successfully translating AI hits into novel therapeutics. She has more than 15 years of experience in large and small molecule drug discovery and development, and more than 30 publications in top-tier journals with research focused on diverse pathways in immunology, neuroscience, and fibrotic diseases. In her most recent role at Amgen, Heather spearheaded multiple immune modulatory therapies, as well as building and managing a robust team of scientists and associates focused on filling the pipeline with new therapies for fibrotic and inflammatory diseases, and immuno-oncology. She holds a PhD in Neuroscience from the University of North Carolina at Chapel Hill and completed a National Multiple Sclerosis Society postdoctoral fellowship at Harvard Medical School and the Dana-Farber Cancer Institute.

Heather Arnett's Network

Agenda Sessions

  • Using AI to discover novel therapeutics for fibrosis

    , 11:15am
  • Discussion Panel: Challenges in the application of AI and Machine Learning in Drug Discovery - Different challenges for different entities

    , 8:30am